Kentaro Kogure

Details der Publikationsliste

Zeitraum

2004 - 2009

Anzahl

17

Co-Autoren

Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes (2009)

Homhuan, Atthachai, Kogure, Kentaro, Nakamura, Takashi, Shastri, Nilabh, Harashima, Hideyoshi

To improve uptake and cross-presentation of exogenous antigens (Ag) by dendritic cells (DCs), octaarginine-modified liposomes (R8-Lip) were used as a novel strategy for protein-Ag transduction....

MITO-Porter : a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion (2008)

Yamada, Yuma, Akita, Hidetaka, Kamiya, Hiroyuki, Kogure, Kentaro, Yamamoto, Takenori, Shinohara, Yasuo, ...

Mitochondria are the principal producers of energy in higher cells. Mitochondrial dysfunction is implicated in a variety of human diseases, including cancer and neurodegenerative disorders. Effective...

Multifunctional envelope-type nano device for non-viral gene delivery: Concept and application of Programmed Packaging (2007)

Kogure, Kentaro, Akita, Hidetaka, Harashima, Hideyoshi

In this review, a new concept called “Programmed Packaging” is proposed for developing non-viral gene delivery systems. A Multifunctional Envelope-type Nano Device (MEND) was developed based on...

Octaarginine-modified multifunctional envelope-type nano device for siRNA (2007)

Nakamura, Yoshio, Kogure, Kentaro, Futaki, Shiroh, Harashima, Hideyoshi

The multifunctional envelope-type nano device (MEND) is a novel non-viral gene delivery system for plasmid DNA (pDNA) and oligodeoxynucleotides (ODN). We showed previously that octaarginine-modified...

Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression. (2007)

Akita, Hidetaka, Ito, Rie, Kamiya, Hiroyuki, Kogure, Kentaro, Harashima, Hideyoshi

Background: Heterogeneity of transgene expression, the presence or absence (below the limit of detection) of transgene expression on a cell-by-cell basis, is a severe disadvantage in the use of...

Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression. (2007)

Akita, Hidetaka, Ito, Rie, Kamiya, Hiroyuki, Kogure, Kentaro, Harashima, Hideyoshi

Background: Heterogeneity of transgene expression, the presence or absence (below the limit of detection) of transgene expression on a cell-by-cell basis, is a severe disadvantage in the use of...

Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide (2006)

Nakamura, Yoshio, Kogure, Kentaro, Yamada, Yuma, Futaki, Shiroh, Harashima, Hideyoshi, 小暮, 健太朗

A multifunctional envelope-type nano device (MEND) was developed for use as an efficient non-viral system for the delivery of plasmid DNA (pDNA) using octaarginine (R8) as an internalizing ligand....

Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide (2006)

Nakamura, Yoshio, Kogure, Kentaro, Yamada, Yuma, Futaki, Shiroh, Harashima, Hideyoshi

A multifunctional envelope-type nano device (MEND) was developed for use as an efficient non-viral system for the delivery of plasmid DNA (pDNA) using octaarginine (R8) as an internalizing ligand....

Significant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotide (2006)

Nakamura, Yoshio, Kogure, Kentaro, Yamada, Yuma, Futaki, Shiroh, Harashima, Hideyoshi

A multifunctional envelope-type nano device (MEND) was developed for use as an efficient non-viral system for the delivery of plasmid DNA (pDNA) using octaarginine (R8) as an internalizing ligand....

Non-linear pharmacodynamics in a non-viral gene delivery system: Positive non-linear relationship between dose and transfection efficiency (2006)

Moriguchi, Rumiko, Kogure, Kentaro, Iwasa, Akitada, Akita, Hidetaka, Hideyoshi, Harashima

A remarkable non-linearity was found between dose and transfection activities of non-viral gene delivery systems, such as a Lipofectamine/DNA complex and an octaarginine-modified multifunctional...

Non-linear pharmacodynamics in a non-viral gene delivery system: Positive non-linear relationship between dose and transfection efficiency (2006)

Moriguchi, Rumiko, Kogure, Kentaro, Iwasa, Akitada, Akita, Hidetaka, Hideyoshi, Harashima

A remarkable non-linearity was found between dose and transfection activities of non-viral gene delivery systems, such as a Lipofectamine/DNA complex and an octaarginine-modified multifunctional...

A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids (2005)

Moriguchi, Rumiko, Kogure, Kentaro, Akita, Hidetaka, Futaki, Shiroh, Miyagishi, Makoto, Taira, Kazunari, ...

A multifunctional envelope-type nano device (MEND) for use in the delivery of siRNA expression plasmids is described. The plasmid DNA encoding anti-luciferase short interfering RNA (siRNA) was...

Construction of a multifunctional envelope-type nano device by a SUV*-fusion method (2005)

Sasaki, Kentaro, Kogure, Kentaro, Chaki, Sinji, Kihira, Yoshitaka, Ueno, Masaharu, Harashima, Hideyoshi

In this review, a new concept called “Programmed Packaging” is proposed for developing non-viral gene delivery systems. A Multifunctional Envelope-type Nano Device (MEND) was developed based on...

Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method (2004)

Kogure, Kentaro, Moriguchi, Rumiko, Sasaki, Kentaro, Ueno, Masaharu, Futaki, Shiroh, Harashima, Hideyoshi

The previous termdevelopment of a multifunctional envelope-type nano devicenext term (MEND) for use in previous terma non-viralnext term gene delivery system using previous terma novel lipid film...

Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.

Tokumura, Akira, Sinomiya, Junya, Kishimoto, Seishi, Tanaka, Tamotsu, Kogure, Kentaro, Sugiura, Takayuki, ...

Lysophosphatidic acid (LPA) is a physiological agonist that is produced by lysophospholipase D, phospholipase A(1) and phospholipase A(2) in the blood of animals. It exerts diverse biological actions...

Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.

Tokumura, Akira, Sinomiya, Junya, Kishimoto, Seishi, Tanaka, Tamotsu, Kogure, Kentaro, Sugiura, Takayuki, ...

Lysophosphatidic acid (LPA) is a physiological agonist that is produced by lysophospholipase D, phospholipase A(1) and phospholipase A(2) in the blood of animals. It exerts diverse biological actions...